CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-06 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 252,380 | ||
| 2023-01-04 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 108,812 |
| 2023-01-04 | Coulie Bernard President and CEO | Sale | −15,000 | $19.06 | $286K | 93,812 |
| 2023-01-04 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 267,380 | ||
| 2023-01-03 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 108,812 |
| 2023-01-03 | Coulie Bernard President and CEO | Sale | −15,000 | $19.33 | $290K | 93,812 |
| 2023-01-03 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 282,380 | ||
| 2022-12-22 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +4,000 | $2.08 | $8K | 84,424 |
| 2022-12-22 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −4,000 | 146,097 | ||
| 2022-12-22 | Ouimette Mike General Counsel & Corp. Sec'y | Sale | −2,928 | $19.38 | $57K | 5,947 |
| 2022-12-20 | Cummings Keith Lamont Chief Financial Officer | Sale | −9,643 | $19.10 | $184K | 80,424 |
| 2022-12-20 | Coulie Bernard President and CEO | Sale | −34,212 | $19.10 | $654K | 93,812 |
| 2022-12-20 | Lefebvre Eric Chief Medical Officer | Sale | −10,887 | $19.10 | $208K | 144,426 |
| 2022-12-20 | Ouimette Mike General Counsel & Corp. Sec'y | Sale | −4,719 | $19.10 | $90K | 8,875 |
| 2022-12-20 | Hull Hans Chief Business Officer | Sale | −8,748 | $19.10 | $167K | 138,191 |
| 2022-12-19 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +19,375 | 90,067 | ||
| 2022-12-19 | Coulie Bernard President and CEO | Grant or award | +68,751 | 128,024 | ||
| 2022-12-19 | Lefebvre Eric Chief Medical Officer | Grant or award | +21,876 | 155,313 | ||
| 2022-12-19 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +13,594 | 13,594 | ||
| 2022-12-19 | Hull Hans Chief Business Officer | Grant or award | +17,578 | 146,939 |
Page 13 of 19 · 379 trades